Les Sulewski
Stock Analyst at Truist Securities
(0.75)
# 4,011
Out of 5,182 analysts
19
Total ratings
35.29%
Success rate
-14.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $18 | $6.79 | +165.10% | 1 | Mar 5, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $15 → $17 | $12.57 | +35.24% | 4 | Mar 2, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $38 → $42 | $31.26 | +34.36% | 3 | Feb 18, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.58 | +43.37% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $25.55 | +9.59% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $32.78 | +46.43% | 3 | Nov 7, 2025 |
Vanda Pharmaceuticals
Mar 5, 2026
Initiates: Buy
Price Target: $18
Current: $6.79
Upside: +165.10%
Amneal Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $17
Current: $12.57
Upside: +35.24%
Teva Pharmaceutical Industries
Feb 18, 2026
Maintains: Buy
Price Target: $38 → $42
Current: $31.26
Upside: +34.36%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.58
Upside: +43.37%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $25.55
Upside: +9.59%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $32.78
Upside: +46.43%